Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
for Mesial Temporal Lobe Epilepsy
35 locations incl. Birmingham
Sponsor: Neurona Therapeutics
Sex: All·Age: 18 - 75
Code: NCT05135091·Phase 3·Recruiting